openPR Logo
Press release

Tyrosine Kinase JAK Inhibitors Market Pegged for Robust Expansion by 2026

08-20-2018 07:50 PM CET | Health & Medicine

Press release from: Transparency Market Research

Tyrosine Kinase JAK Inhibitors Market Pegged for Robust

Tyrosine kinases are enzymes capable of transferring the phosphate group from ATP (adenosine triphosphate) to a cellular protein. They function as an on or off switch for several cellular mechanisms. On the protein, the phosphate group is affiliated to the tyrosine amino acid. Tyrosine kinases are a subclass of the larger group of protein kinases that connect phosphate groups to extra amino acids (threonine and serine). In interconnecting signals in a cell (signal transduction) and cellular activities such as cell division regulation, proteins phosphorylation is an important mechanism, which is performed by kinases.

View Report -

https://www.transparencymarketresearch.com/tyrosine-kinase-jak-inhibitors-market.html

Due to their role in cell survival, migration, and proliferation, various tyrosine kinases are involved in the development of cancer. Mutation of protein kinases can cause uncontrolled growth of the cell, which can lead to the development of cancer. Therefore, kinase inhibitors such as imatinib are effective for the treatment of cancer. There are around 90 tyrosine kinases in the mammalian genome, with approximately 30 non-receptor tyrosine kinases and 60 receptor tyrosine kinases.

Receptor tyrosine kinases consist of intracellular domains with tyrosine kinases enzymatic activity, a transmembrane domain, as well as extracellular areas involved in binding of ligands. Jakinibs or JAK inhibitors, also known as Janus kinase inhibitors, are molecules or medicine that offer therapeutic activity by inhibiting one or more than one enzymes of the Janus kinase family (TYK2, JAK3, JAK2, JAK1) by blocking the JAK-STAT signaling pathway. These JAK inhibitors have therapeutic use in several types of inflammatory diseases and in cancer treatment. JAK3 inhibitors are very important in the treatment of several autoimmune diseases. Several companies are performing the development process for selective JAK3 inhibitors.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45174

Rise in prevalence of autoimmune diseases and cancer are major drivers of the Tyrosine Kinase JAK Inhibitors Market. Moreover, increased application of JAK inhibitors in inflammatory diseases and increase in investment from pharmaceutical companies are some other drivers of the tyrosine kinase JAK inhibitors market. However, stringent government regulations, high cost of treatment, and lack of funds for conducting research are likely to hamper the market during the forecast period.

The global tyrosine kinase JAK inhibitors market can be segmented based on type, , application, and region. Based on type, the tyrosine kinase JAK inhibitors market can be classified into tofacitinib, ruxolitinib, and baricitinib. In terms of application, the tyrosine kinase JAK inhibitors market can be categorized into rheumatoid arthritis (RA), polycythemia vera (PCV), myelofibrosis (MF), and others.

Based on region, the global tyrosine kinase JAK inhibitors market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global tyrosine kinase JAK inhibitors market due to availability of advanced medications and increased health expenses. Awareness among the people about diseases is also a major factor boosting the market in the region. The tyrosine kinase JAK inhibitors market in Asia Pacific is anticipated to expand at a rapid pace due to increase in prevalence of cancer and autoimmune diseases. Lack of awareness about diseases and unavailability of advanced medication and treatment in underdeveloped countries such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the tyrosine kinase JAK inhibitors market in Middle East & Africa.

Top players of the global market of tyrosine kinase JAK inhibitors are Pfizer Inc., Incyte Corporation, Novartis AG, Eli Lilly and Company, Gilead, Sanofi, Galapagos NV, AbbVie Inc., Vertex Pharmaceuticals Incorporated, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., CELGENE CORPORATION, and CTI BioPharma Corp. among others.

Enquiry for discount on this report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=45174

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tyrosine Kinase JAK Inhibitors Market Pegged for Robust Expansion by 2026 here

News-ID: 1189511 • Views:

More Releases from Transparency Market Research

Cellular Modem Industry Poised for Significant Growth, Projected to Reach US$ 16.2 Billion by 2034
Cellular Modem Industry Poised for Significant Growth, Projected to Reach US$ 16 …
The Global Cellular Modem Market (携帯電話モデム市場) is poised for substantial growth, projected to expand from US$ 5.2 billion in 2023 to US$ 16.2 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 10.6%. This growth is propelled by escalating broadband connections worldwide and the increasing adoption of portable 5G networks, particularly in the military and defense sectors. Download Sample PDF from Here- https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70089&utm_source=Openpr&utm_medium=Amit Market Dynamics: Cellular modems serve as crucial
Global System Integrator Market Poised for Significant Growth, Valued at $52.3 Billion by 2034: TMR Analysis
Global System Integrator Market Poised for Significant Growth, Valued at $52.3 B …
The Global System Integrator Market, valued at approximately $28.3 billion in 2023, is projected to experience substantial growth, with an estimated compound annual growth rate (CAGR) of 5.8% from 2024 to 2034. This surge is expected to elevate the market's value to around $52.3 billion by the end of the forecast period. The rise in the adoption of industrial robots and a surge in technological advancements are pivotal factors propelling the
Wearable AI Market Poised for Significant Growth, Expected to Reach US$ 146.2 Billion by 2034
Wearable AI Market Poised for Significant Growth, Expected to Reach US$ 146.2 Bi …
The Global Wearable AI Market (Markt für tragbare KI), valued at $60.8 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2024 to 2034, reaching a remarkable $146.2 billion by the end of the forecast period. This substantial growth is primarily fueled by the rising adoption of cognitive wearables among persons with disabilities and a growing focus on efficiency, productivity, and safety
Dark Fiber Market Expected to Expand at 4.5% CAGR, Reaching US$ 10.2 Billion by 2034; TMR Analysis
Dark Fiber Market Expected to Expand at 4.5% CAGR, Reaching US$ 10.2 Billion by …
The Global Dark Fiber Market (ダークファイバー市場), valued at US$ 6.4 Bn in 2023, is poised for substantial growth over the next decade. According to recent industry analysis, the market is projected to expand at a CAGR of 4.5% from 2024 to 2034, reaching an estimated value of US$ 10.2 Bn by the end of 2034. The rising adoption of 5G networks and the significant expansion of data center projects across the

All 5 Releases


More Releases for JAK

Janus Kinase (JAK) Inhibitors Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Janus Kinase (JAK) Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Janus Kinase (JAK) Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Janus Kinase (JAK)
Global Janus Kinase (JAK) Inhibitors Market to Witness a Pronounce Growth During …
LP INFORMATION offers a latest published report on Janus Kinase (JAK) Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Janus Kinase (JAK) Inhibitors market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million
JAK-Metalli named Swedish Steel Prize 2018 finalist
/ins For developing a new cutting solution for vegetation management that is safer, less energy intensive and more durable, JAK-Metalli has been nominated for the Swedish Steel Prize 2018. The Swedish Steel Prize is awarded annually to recognize the most innovative design utilizing high-performance steel. JAK-Metalli Oy, from Finland, is one of the four finalists for this year’s prize, which will be awarded during a ceremony in Stockholm, Sweden on May
Tyrosine Kinase JAK Inhibitors Market Sees Promising Growth to 2022
HTF MI presents an in-depth assessment of current Tyrosine Kinase JAK Inhibitors key market drivers, market size and trends and Asia-Pacific Tyrosine Kinase JAK Inhibitors opportunities, challenges, and restraints as well as key market segments, technological updates, impact of any regulatory policies as well as key market segments. The research study provides forecasts for Tyrosine Kinase JAK Inhibitors investments till 2022. If you are involved in the Tyrosine Kinase JAK
Global Tyrosine Kinase JAK Inhibitors Market Challenges & Industry Analysis by 2 …
Qyresearchreports include new market research report "Global Tyrosine Kinase JAK Inhibitors Market Research Report 2018" to its huge collection of research reports. Tyrosine Kinase JAK Inhibitors Market Research Report is a comprehensive market study, which has been created with a sole goal to armor existing and new players to gain advantage over their competitors. For the development of the report, proven research methodology and reliable analytical tools are applied to gain
In-depth research on Global Janus Kinase (JAK) Inhibitors Market 2017
MarketResearchReports.Biz presents this most up-to-date research on "Janus Kinase (JAK) Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2017" DelveInsights, Janus Kinase (JAK) Inhibitors- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and pipeline drugs that fall under Janus Kinase (JAK) Inhibitors. This report